<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01815697</url>
  </required_header>
  <id_info>
    <org_study_id>NSFC-81070488</org_study_id>
    <nct_id>NCT01815697</nct_id>
  </id_info>
  <brief_title>Effect of Enhanced External Counterpulsation on Lower Urinary Tract Symptoms</brief_title>
  <acronym>EECPLUTS</acronym>
  <official_title>A Prospective, Randomized Study of Enhanced External Counterpulsation in Patients With Lower Urinary Tract Symptoms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>First Affiliated Hospital, Sun Yat-Sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to access the effects of Enhanced External Counterpulsation
      treatment on lower urinary tract symptoms in patients with benign prostatic hyperplasia.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with benign prostatic hyperplasia and will be randomized into two groups: EECP
      intervention or not. Lower urinary tract symptoms, hemodynamic parameters, vascular
      endothelial function will be measured and compared
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 2013</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients with benign prostatic hyperplasia are assigned to two groups in parallel for the duration of the study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline in lower urinary tract symptoms evaluated by International Prostate Symptom Score</measure>
    <time_frame>7 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary flow rate</measure>
    <time_frame>7 weeks</time_frame>
    <description>Change from baseline in urinary flow rate</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Endothelial function</measure>
    <time_frame>7 weeks</time_frame>
    <description>Change from baseline in flow- mediated dilation (FMD) accessed by color Doppler ultrasound system</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Lower Urinary Tract Symptoms</condition>
  <arm_group>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Men with benign prostatic hyperplasia receive 35- 36 hours Enhanced External Counterpulsation treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Men with benign prostatic hyperplasia without Enhanced External Counterpulsation treatment as control</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Enhanced External Counterpulsation</intervention_name>
    <description>Enhanced external counterpulsation (EECP) is mainly used in cardiovascular and cerebrovascular diseases, which has been proven to be able to improve microcirculation and endothelial function. EECP therapy is done by sequential inflation of 3 sets of cuffs wrapped around the lower extremities during diastole and deflation of the cuffs during systole. The systolic deflation/ Diastolic inflation sequence of EECP leads to systolic unloading and diastolic augmentation, resulting in increased blood flow in a pulsatile manner. The patients will receive 35-36 hours EECP intervention, 1-hour session every day over a 7-week period.</description>
    <arm_group_label>Enhanced External Counterpulsation</arm_group_label>
    <other_name>EECP</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. men over 18 years old;

          2. provide signed informed consent;

          3. existence of lower urinary tract symptoms

          4. agree not to use any lower urinary tract symptoms treatment at least one month;

          5. suitable for receiving EECP treatment

        Exclusion Criteria:

          1. history of long drug abuse;

          2. pelvic, spine, brain trauma or surgery;

          3. endocrine, liver, lung, kidney disease, malignancies, hematological disorders;

          4. Severe infection without effective control；

          5. lower limbs deep vein thrombosis；

          6. Large area of ulcerative rash；

          7. unsuitable for receiving EECP treatment
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yan Zhang, M. D.</last_name>
    <role>Study Director</role>
    <affiliation>First Affiliated Hospital, Sun Yat-Sen University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Yadong Zhang, M. D.</last_name>
    <phone>862087755766</phone>
    <phone_ext>8373</phone_ext>
    <email>zhyadong@mail.sysu.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zi Wan, M. D.</last_name>
    <phone>862087755766</phone>
    <phone_ext>8227</phone_ext>
    <email>zi_wan2012@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>The First Affiliated Hospital, Sun Yat- sen University</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <zip>510080</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Weiwei Zhang, PhD</last_name>
      <phone>8620-87334871</phone>
      <email>zhweiw2@mail.sysu.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>Chunhua Deng, M. D.</last_name>
      <phone>0086-13501519349</phone>
      <email>dch0313@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2013</study_first_submitted>
  <study_first_submitted_qc>March 20, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 21, 2013</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>First Affiliated Hospital, Sun Yat-Sen University</investigator_affiliation>
    <investigator_full_name>Chen Sheng Fu,MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Lower Urinary Tract Symptoms</keyword>
  <keyword>Benign Prostatic Hyperplasia</keyword>
  <keyword>Urinary Retention</keyword>
  <keyword>Vascular Endothelium</keyword>
  <keyword>Counterpulsation, External</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lower Urinary Tract Symptoms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

